Iovance Biotherapeutics IOVA
NASDAQ IOVA
$8.09 +0.01 (+0.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Iovance Biotherapeutics (IOVA) Short term Debt (2012)

Updated

Iovance Biotherapeutics (IOVA) posted Short term Debt of $250,000 for Q4 2012, unchanged from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Short term Debt (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Iovance Biotherapeutics 3.74 Bn 2.45 Bn 73.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 250,000.00
Sep 30, 2012 250,000.00
API Access

Iovance Biotherapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=IOVA&period=max&api_key=YOUR_API_KEY